News Headline Summary

Medtronic (MDT) says the first patient is being treated in Medtronic clinical trial evaluating corevalue system in intermediate-risk patients

Reaction details:

- Medtronic shares unmoved by this latest news; trades USD 41.12 last (+0.6%).

Print 19:00, 16 Nov 2012 - US Equities - Source: Newswires